Cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis

mBio

Volumn 4, Issue 6, 2013, Pages

  Zacharia, Vineetha M ^a   Manzanillo, Paolo S ^b   Nair, Vidhya R ^a   Marciano, Denise K ^a   Kinch, Lisa N ^a   Grishin, Nick V ^a   Cox, Jeffery S ^b   Shiloh, Michael U ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1; ANTIINFECTIVE AGENT; TRANSPOSON; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CONTROLLED STUDY; COR GENE; DISEASE MODEL; ESCHERICHIA COLI; GENE DISRUPTION; GENE LIBRARY; HETEROLOGOUS EXPRESSION; INFECTION RESISTANCE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSPOSON; TUBERCULOSIS; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL LOAD; BAGG ALBINO MOUSE; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SURVIVAL; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; CARBON MONOXIDE; DISEASE MODELS, ANIMAL; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION; MICE; MICE, INBRED BALB C; MUTAGENESIS, INSERTIONAL; MYCOBACTERIUM TUBERCULOSIS; SURVIVAL ANALYSIS; TUBERCULOSIS; VIRULENCE; VIRULENCE FACTORS;

EID: 84891603702     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00721-13     Document Type: Article

References (58)

1. Huynh KK, Joshi SA, Brown EJ. 2011. A delicate dance: host response to mycobacteria. Curr. Opin. Immunol. 23:464-472.
2. Liu PT, Modlin RL. 2008. Human macrophage host defense against Mycobacterium tuberculosis. Curr. Opin. Immunol. 20:371-376.
3. Nathan C, Shiloh MU. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. U. S. A. 97:8841-8848.
4. Rohde K, Yates RM, Purdy GE, Russell DG. 2007. Mycobacterium tuberculosis and the environment within the phagosome. Immunol. Rev. 219:37-54.
5. Davis AS, Vergne I, Master SS, Kyei GB, Chua J, Deretic V. 2007. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLOS Pathog. 3:e186. doi:10.1371/journal.ppat.0030186.
6. Deghmane AE, Soualhine H, Bach H, Sendide K, Itoh S, Tam A, Noubir S, Talal A, Lo R, Toyoshima S, Av-Gay Y, Hmama Z. 2007. Lipoamide dehydrogenase mediates retention of coronin-1 on BCG vacuoles, leading to arrest in phagosome maturation. J. Cell Sci. 120:2796-2806.
7. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL, Heuser J, Russell DG. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-681.
8. Zhang Y, Heym B, Allen B, Young D, Cole S. 1992. The catalaseperoxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
9. Li Z, Kelley C, Collins F, Rouse D, Morris S. 1998. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J. Infect. Dis. 177:1030-1035.
10. Darwin KH, Nathan CF. 2005. Role for nucleotide excision repair in virulence of Mycobacterium tuberculosis. Infect. Immun. 73:4581-4587.
11. Darwin KH, Ehrt S, Gutierrez-Ramos JC, Weich N, Nathan CF. 2003. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302:1963-1966.
12. Bryk R, Lima CD, Erdjument-Bromage H, Tempst P, Nathan C. 2002. Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science 295:1073-1077.
13. Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S. 2008. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat. Med. 14:849-854.
14. Vandal OH, Roberts JA, Odaira T, Schnappinger D, Nathan CF, Ehrt S. 2009. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J. Bacteriol. 191:625-631.
15. Abramovitch RB, Rohde KH, Hsu FF, Russell DG. 2011. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Mol. Microbiol. 80: 678-694.
16. Tan MP, Sequeira P, Lin WW, Phong WY, Cliff P, Ng SH, Lee BH, Camacho L, Schnappinger D, Ehrt S, Dick T, Pethe K, Alonso S. 2010. Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses. PLoS One 5:e13356. doi: 10.1371/journal.pone.0013356.
17. Sjostrand T. 1952. The formation of carbon monoxide by the decomposition of haemoglobin in vivo. Acta Physiol. Scand. 26:338-344.
18. Tenhunen R, Marver HS, Schmid R. 1968. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U. S. A. 61:748-755.
19. Maines MD. 1988. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2:2557-2568.
20. Maines MD. 2004. The heme oxygenase system: past, present, and future. Antioxid. Redox Signal. 6:797-801.
21. Ryter SW, Morse D, Choi AM. 2004. Carbon monoxide: to boldly go where NO has gone before. Sci. STKE 2004:RE6. doi:10.1126/stke.2302004re6.
22. Biernacki WA, Kharitonov SA, Barnes PJ. 2001. Exhaled carbon monoxide in patients with lower respiratory tract infection. Respir. Med. 95: 1003-1005.
23. Paredi P, Shah PL, Montuschi P, Sullivan P, Hodson ME, Kharitonov SA, Barnes PJ. 1999. Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax 54:917-920.
24. Uasuf CG, Jatakanon A, James A, Kharitonov SA, Wilson NM, Barnes PJ. 1999. Exhaled carbon monoxide in childhood asthma. J. Pediatr. 135: 569-574.
25. Antuni JD, Kharitonov SA, Hughes D, Hodson ME, Barnes PJ. 2000. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 55:138-142.
26. Paredi P, Kharitonov SA, Barnes PJ. 2003. Exhaled carbon monoxide in lung disease. Eur. Respir. J. 21:197-198. doi:10.1183/09031936.02.00071802. (Author reply.)
27. Shiloh MU, Manzanillo P, Cox JS. 2008. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3:323-330.
28. Kumar A, Deshane JS, Crossman DK, Bolisetty S, Yan BS, Kramnik I, Agarwal A, Steyn AJ. 2008. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 283:18032-18039.
29. Regev D, Surolia R, Karki S, Zolak J, Montes-Worboys A, Oliva O, Guroji P, Saini V, Steyn AJ, Agarwal A, Antony VB. 2012. Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria. Lab. Invest. 92:1541-1552.
30. Silva-Gomes S, Appelberg R, Larsen R, Soares MP, Gomes MS. 2013. Heme catabolism by heme oxygenase-1 confers host resistance to mycobacterium infection. Infect. Immun. 81:2536-2545.
31. Bach FH. 2006. Carbon monoxide: from the origin of life to molecular medicine. Trends Mol. Med. 12:348-350.
32. Weigel PH, Englund PT. 1975. Inhibition of DNA replication in Escherichia coli by cyanide and carbon monoxide. J. Biol. Chem. 250: 8536-8542.
33. Nobre LS, Seixas JD, Romão CC, Saraiva LM. 2007. Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob. Agents Chemother. 51:4303-4307.
34. Davidge KS, Sanguinetti G, Yee CH, Cox AG, McLeod CW, Monk CE, Mann BE, Motterlini R, Poole RK. 2009. Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. J. Biol. Chem. 284:4516-4524.
35. Desmard M, Davidge KS, Bouvet O, Morin D, Roux D, Foresti R, Ricard JD, Denamur E, Poole RK, Montravers P, Motterlini R, Boczkowski J. 2008. A carbon monoxide-releasing molecule (corm-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J. 23:1023-1031.
36. Sassetti CM, Boyd DH, Rubin EJ. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48: 77-84.
37. You MK, Shin HY, Kim YJ, Ok SH, Cho SK, Jeung JU, Yoo SD, Kim JK, Shin JS. 2010. Novel bifunctional nucleases, OmBBD and AtBBD1, are involved in abscisic acid-mediated callose deposition in Arabidopsis. Plant Physiol. 152:1015-1029.
38. Singh A, Crossman DK, Mai D, Guidry L, Voskuil MI, Renfrow MB, Steyn AJ. 2009. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog. 5:e1000545. doi:10.1371/journal.ppat.1000545.
39. Tavares AF, Teixeira M, Romão CC, Seixas JD, Nobre LS, Saraiva LM. 2011. Reactive oxygen species mediate bactericidal killing elicited by carbon monoxide-releasing molecules. J. Biol. Chem. 286:26708-26717.
40. Park SW, Hwang EH, Park H, Kim JA, Heo J, Lee KH, Song T, Kim E, Ro YT, Kim SW, Kim YM. 2003. Growth of mycobacteria on carbon monoxide and methanol. J. Bacteriol. 185:142-147.
41. King GM. 2003. Uptake of carbon monoxide and hydrogen at environmentally relevant concentrations by mycobacteria. Appl. Environ. Microbiol. 69:7266-7272.
42. Chan J, Xing Y, Magliozzo RS, Bloom BR. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
43. Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD. 2004. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52:1291-1302.
44. O'Brien L, Carmichael J, Lowrie DB, Andrew PW. 1994. Strains of mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect. Immun. 62:5187-5190.
45. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
46. Venugopal A, Bryk R, Shi S, Rhee K, Rath P, Schnappinger D, Ehrt S, Nathan C. 2011. Virulence of mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. Cell Host Microbe 9:21-31.
47. Motterlini R, Otterbein LE. 2010. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 9:728-743.
48. Boczkowski J, Poderoso JJ, Motterlini R. 2006. Co-metal interaction: vital signaling from a lethal gas. Trends Biochem. Sci. 31:614-621.
49. Wayne LG. 1976. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am. Rev. Respir. Dis. 114:807-811.
50. Rubin EJ, Akerley BJ, Novik VN, Lampe DJ, Husson RN, Mekalanos JJ. 1999. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc. Natl. Acad. Sci. U. S. A. 96:1645-1650.
51. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs, WR, Jr, Bloom BR. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
52. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
53. Pei J, Tang M, Grishin NV. 2008. PROMALS3D web server for accurate multiple protein sequence and structure alignments. Nucleic Acids Res. 36:W30-W34.
54. Frickey T, Lupas A. 2004. CLANS: a Java application for visualizing protein families based on pairwise similarity. Bioinformatics 20: 3702-3704.
55. Pei J, Grishin NV. 2001. AL2CO: calculation of positional conservation in a protein sequence alignment. Bioinformatics 17:700-712.
56. Wayne LG, Hayes LG. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
57. Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS. 2012. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 11:469-480.
58. Ohol YM, Goetz DH, Chan K, Shiloh MU, Craik CS, Cox JS. 2010. Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. Cell Host Microbe 7:210-220.